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Background potassium currents play an important role in the regulation of the 
resting membrane potential and excitability of mammalian neurons. Recently cloned two- 
pore domain potassium channels (K2p) are believed to underlie these currents. The roles 
of K2P channels in general anesthesia and neuroprotection have been proposed recently. 
In view of this, we investigated the ability of trichloroethanol (an active 
metabolite of the non-volatile general anesthetic cldoral hydrate, widely used as a 
pediatric sedative) to modulate the activity of human TREK-1 and TRAAK channels. We 
found that trichloroethanol potently activates both hTREK-1 and hTRAAK channels at 
pharmacologically relevant concentrations. The parent compound chloral hydrate was 
also found to augtnent the activity of both the channels reversibly. Studies with carboxy- 
terminal deletion mutants (hTREK-1A89, hTREK-1 A1 00 and hTREK-1 A1 19), suggested 
that C-terminal tail is not essential for the activation of TREK-1 by trichloroethanol. Our 
findings identify TREK-1 and TRCL4K channels as molecular targets for trichloroethanol 
and we propose that activation of both these channels might contribute to the CNS 
depressant effects of chloral hydrate. Another channel TASK-2, which is essentially 
absent in the human brain was also found to be potently activated by both 
trichloroethanol and chloral hydrate. 
In another series of experiments, we studied the effects of methyl xanthines 
caffeine and theophylline on hTREK-1 channels. Caffeine and theophylline are used for 
therapeutic purposes and frequently cause life-threatening convulsive seizures due to 
systemic toxicity. The mechanisms for the epileptogenicity of caffeine and theophylline 
are not clear. Recent experiments using knockout mice provided direct evidence for a role 
for TREK-1 in the control of epileptogenesis. We hypothesized that the epileptogenicity 
of caffeine and theophylline may be related to the inhibition of TREK-1 channels. We 
investigated this possibility and observed massive inhibition of TREK-1 channels at 
toxicologically relevant concentrations. Experiments with the mutant TREK-1 channel 
(S348A mutant) suggested the involvement of cANP/PKA pathway in the inhibition of 
TREK-1 channels by caffeine and theophylline. We suggest that inhibition of TREK-1 
channels may contribute to the convulsive seizures induced by toxic levels of caffeine 
and theophylline. 
Local anesthetics exhibit their clinical effects not only by binding to voltage-gated 
sodium channels, but also by interacting with other ion channels such as potassium 
channels. Because of the physiological significance of TREK-1 channels and their 
abundant expression in peripheral sensory neurons, we investigated the effects of 
lidocaine to see whether its interaction with 'REK-1 channels contribute to the 
conduction blockade. Lidocaine caused dose-dependent inhibition of TREK-1 channels 
and the inhibition was voltage-independent. Cytoplasmic C-terminal tail is critically 
required for lidocaine action. Inhibition of TREK-1 channels is achieved at 
concentrations for iiz vivo action and this effect may have implications for the clinically 
observed drug action of lidocaine. 
